Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Phase 2
100
about 1.7 years
18+
2 sites in VA
What this study is about
Researchers are testing whether early screening for heart complications and treatment for iron overload can prevent heart problems and reduce hospitalizations in people with sickle cell disease. The trial will involve using medications like deferasirox, deferiprone, or deferoxamine, along with tests such as echocardiography and electrocardiograms (ECG).
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Deferasirox
- 2.Take Deferiprone
- 3.Take Deferoxamine
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
deferasirox, deferiprone, deferoxamine
oral (Oral Tablet)
Primary: Incidence of Hospitalization for Sickle Cell Disease Related Complications, Length of Stay for SCD-Related Complications
diagnostic